3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myeloproliferative Disorders
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Congenital Abnormalities
1
Carcinoma, Non-Small-Cell Lung
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
3-Iodobenzylguanidine
3
cabozantinib
2
tipifarnib
1
pembrolizumab
1
pazopanib
1
lutetium Lu 177 dotatate
1
lenvatinib
1
guadecitabine
1
fostamatinib
1
copper dotatate CU-64
1
atezolizumab
1
Temozolomide
1
Surgical Procedures, Operative
1
Sunitinib
1
Phenoxybenzamine
1
Nivolumab
1
Lutetium-177
1
Lutetium
1
Iodine-131
1
Everolimus
1
Erlotinib Hydrochloride
1
Doxazosin
1
Capecitabine
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pheochromocytoma
×
Biological Therapy
×
Clear all
No trials found.